81 FR 5473 - Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration

Federal Register Volume 81, Issue 21 (February 2, 2016)

Page Range		5473-5474
FR Document		2016-01819

The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITF) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the Federal Register on April 11, 1988 (53 FR 11970), and subsequently revised in the Federal Register on June 9, 1994 (59 FR 29908); September 30, 1997 (62 FR 51118); April 13, 2004 (69 FR 19644); November 25, 2008 (73 FR 71858); December 10, 2008 (73 FR 75122); and on April 30, 2010 (75 FR 22809). A notice listing all currently HHS-certified laboratories and IITFs is published in the Federal Register during the first week of each month. If any laboratory or IITF certification is suspended or revoked, the laboratory or IITF will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory or IITF has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end and will be omitted from the monthly listing thereafter. This notice is also available on the Internet at http:// www.samhsa.gov/workplace.

Federal Register, Volume 81 Issue 21 (Tuesday, February 2, 2016)

[Federal Register Volume 81, Number 21 (Tuesday, February 2, 2016)]
[Notices]
[Pages 5473-5474]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-01819]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Current List of HHS-Certified Laboratories and Instrumented 
Initial Testing Facilities Which Meet Minimum Standards To Engage in 
Urine Drug Testing for Federal Agencies

AGENCY: Substance Abuse and Mental Health Services Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) notifies 
federal agencies of the laboratories and Instrumented Initial Testing 
Facilities (IITF) currently certified to meet the standards of the 
Mandatory Guidelines for Federal Workplace Drug Testing Programs 
(Mandatory Guidelines). The Mandatory Guidelines were first published 
in the Federal Register on April 11, 1988 (53 FR 11970), and 
subsequently revised in the Federal Register on June 9, 1994 (59 FR 
29908); September 30, 1997 (62 FR 51118); April 13, 2004 (69 FR 19644); 
November 25, 2008 (73 FR 71858); December 10, 2008 (73 FR 75122); and 
on April 30, 2010 (75 FR 22809).
    A notice listing all currently HHS-certified laboratories and IITFs 
is published in the Federal Register during the first week of each 
month. If any laboratory or IITF certification is suspended or revoked, 
the laboratory or IITF will be omitted from subsequent lists until such 
time as it is restored to full certification under the Mandatory 
Guidelines.
    If any laboratory or IITF has withdrawn from the HHS National 
Laboratory Certification Program (NLCP) during the past month, it will 
be listed at the end and will be omitted from the monthly listing 
thereafter.
    This notice is also available on the Internet at http://www.samhsa.gov/workplace.

FOR FURTHER INFORMATION CONTACT: Giselle Hersh, Division of Workplace 
Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N03A, Rockville, 
Maryland 20857; 240-276-2600 (voice), 240-276-2610 (fax).

SUPPLEMENTARY INFORMATION: The Mandatory Guidelines were initially 
developed in accordance with Executive Order 12564 and section 503 of 
Public Law 100-71. The ``Mandatory Guidelines for Federal Workplace 
Drug Testing Programs,'' as amended in the revisions listed above, 
requires strict standards that laboratories and IITFs must meet in 
order to conduct drug and specimen validity tests on urine specimens 
for federal agencies.
    To become certified, an applicant laboratory or IITF must undergo 
three rounds of performance testing plus an on-site inspection. To 
maintain that certification, a laboratory or IITF must participate in a 
quarterly performance testing program plus undergo periodic, on-site 
inspections.
    Laboratories and IITFs in the applicant stage of certification are 
not to be considered as meeting the minimum requirements described in 
the HHS Mandatory Guidelines. A HHS-certified

[[Page 5474]]

laboratory or IITF must have its letter of certification from HHS/
SAMHSA (formerly: HHS/NIDA), which attests that it has met minimum 
standards.
    In accordance with the Mandatory Guidelines dated November 25, 2008 
(73 FR 71858), the following HHS-certified laboratories and IITFs meet 
the minimum standards to conduct drug and specimen validity tests on 
urine specimens:

HHS-Certified Instrumented Initial Testing Facilities

Dynacare, 6628 50th Street NW., Edmonton, AB Canada T6B 2N7, 780-
784-1190 (Formerly: Gamma-Dynacare Medical Laboratories)

HHS-Certified Laboratories

ACM Medical Laboratory, Inc., 160 Elmgrove Park, Rochester, NY 
14624, 585-429-2264
Aegis Analytical Laboratories, Inc., 345 Hill Ave., Nashville, TN 
37210, 615-255-2400 (Formerly: Aegis Sciences Corporation, Aegis 
Analytical Laboratories, Inc., Aegis Analytical Laboratories)
Alere Toxicology Services, 1111 Newton St., Gretna, LA 70053, 504-
361-8989/800-433-3823 (Formerly: Kroll Laboratory Specialists, Inc., 
Laboratory Specialists, Inc.)
Alere Toxicology Services, 450 Southlake Blvd., Richmond, VA 23236, 
804-378-9130 (Formerly: Kroll Laboratory Specialists, Inc., 
Scientific Testing Laboratories, Inc.; Kroll Scientific Testing 
Laboratories, Inc.)
Baptist Medical Center-Toxicology Laboratory, 11401 I-30, Little 
Rock, AR 72209-7056, 501-202-2783 (Formerly: Forensic Toxicology 
Laboratory Baptist Medical Center)
Clinical Reference Lab, 8433 Quivira Road, Lenexa, KS 66215-2802, 
800-445-6917
DrugScan, Inc., 200 Precision Road, Suite 200, Horsham, PA 19044, 
800-235-4890
Dynacare ,* 245 Pall Mall Street, London, ONT, Canada N6A 1P4, 519-
679-1630 (Formerly: Gamma-Dynacare Medical Laboratories)
ElSohly Laboratories, Inc., 5 Industrial Park Drive, Oxford, MS 
38655, 662-236-2609
Fortes Laboratories, Inc., 25749 SW., Canyon Creek Road, Suite 600, 
Wilsonville, OR 97070, 503-486-1023
Laboratory Corporation of America Holdings, 7207 N. Gessner Road, 
Houston, TX 77040, 713-856-8288/800-800-2387
Laboratory Corporation of America Holdings, 69 First Ave., Raritan, 
NJ 08869, 908-526-2400/800-437-4986 (Formerly: Roche Biomedical 
Laboratories, Inc.)
Laboratory Corporation of America Holdings, 1904 Alexander Drive, 
Research Triangle Park, NC 27709, 919-572-6900/800-833-3984 
(Formerly: LabCorp Occupational Testing Services, Inc., CompuChem 
Laboratories, Inc.; CompuChem Laboratories, Inc., A Subsidiary of 
Roche Biomedical Laboratory; Roche CompuChem Laboratories, Inc., A 
Member of the Roche Group)
Laboratory Corporation of America Holdings, 1120 Main Street, 
Southaven, MS 38671, 866-827-8042/800-233-6339 (Formerly: LabCorp 
Occupational Testing Services, Inc.; MedExpress/National Laboratory 
Center)
LabOne, Inc. d/b/a Quest Diagnostics, 10101 Renner Blvd., Lenexa, KS 
66219, 913-888-3927/800-873-8845 (Formerly: Quest Diagnostics 
Incorporated; LabOne, Inc.; Center for Laboratory Services, a 
Division of LabOne, Inc.)
MedTox Laboratories, Inc., 402 W. County Road D, St. Paul, MN 55112, 
651-636-7466/800-832-3244
MetroLab-Legacy Laboratory Services, 1225 NE 2nd Ave., Portland, OR 
97232, 503-413-5295/800-950-5295
Minneapolis Veterans Affairs Medical Center, Forensic Toxicology 
Laboratory, 1 Veterans Drive, Minneapolis, MN 55417, 612-725-2088, 
Testing for Veterans Affairs (VA) Employees Only
National Toxicology Laboratories, Inc., 1100 California Ave., 
Bakersfield, CA 93304, 661-322-4250/800-350-3515
One Source Toxicology Laboratory, Inc., 1213 Genoa-Red Bluff, 
Pasadena, TX 77504, 888-747-3774 (Formerly: University of Texas 
Medical Branch, Clinical Chemistry Division; UTMB Pathology-
Toxicology Laboratory)
Pacific Toxicology Laboratories, 9348 DeSoto Ave., Chatsworth, CA 
91311, 800-328-6942 (Formerly: Centinela Hospital Airport Toxicology 
Laboratory)
Pathology Associates Medical Laboratories, 110 West Cliff Dr., 
Spokane, WA 99204, 509-755-8991/800-541-7891x7
Phamatech, Inc., 15175 Innovation Drive, San Diego, CA 92128, 888-
635-5840
---------------------------------------------------------------------------

    * The Standards Council of Canada (SCC) voted to end its 
Laboratory Accreditation Program for Substance Abuse (LAPSA) 
effective May 12, 1998. Laboratories certified through that program 
were accredited to conduct forensic urine drug testing as required 
by U.S. Department of Transportation (DOT) regulations. As of that 
date, the certification of those accredited Canadian laboratories 
will continue under DOT authority. The responsibility for conducting 
quarterly performance testing plus periodic on-site inspections of 
those LAPSA-accredited laboratories was transferred to the U.S. HHS, 
with the HHS' NLCP contractor continuing to have an active role in 
the performance testing and laboratory inspection processes. Other 
Canadian laboratories wishing to be considered for the NLCP may 
apply directly to the NLCP contractor just as U.S. laboratories do.
    Upon finding a Canadian laboratory to be qualified, HHS will 
recommend that DOT certify the laboratory (Federal Register, July 
16, 1996) as meeting the minimum standards of the Mandatory 
Guidelines published in the Federal Register on April 30, 2010 (75 
FR 22809). After receiving DOT certification, the laboratory will be 
included in the monthly list of HHS-certified laboratories and 
participate in the NLCP certification maintenance program.
---------------------------------------------------------------------------

Quest Diagnostics Incorporated, 1777 Montreal Circle, Tucker, GA 
30084, 800-729-6432 (Formerly: SmithKline Beecham Clinical 
Laboratories; SmithKline Bio-Science Laboratories)
Quest Diagnostics Incorporated, 400 Egypt Road, Norristown, PA 
19403, 610-631-4600/877-642-2216 (Formerly: SmithKline Beecham 
Clinical Laboratories; SmithKline Bio-Science Laboratories)
Quest Diagnostics Incorporated, 8401 Fallbrook Ave., West Hills, CA 
91304, 818-737-6370 (Formerly: SmithKline Beecham Clinical 
Laboratories)
Redwood Toxicology Laboratory, 3700650 Westwind Blvd., Santa Rosa, 
CA 95403, 800-255-2159
Southwest Laboratories, 4625 E. Cotton Center Boulevard, Suite 177, 
Phoenix, AZ 85040, 602-438-8507/800-279-0027
STERLING Reference Laboratories, 2617 East L Street, Tacoma, 
Washington 98421, 800-442-0438
U.S. Army Forensic Toxicology Drug Testing Laboratory, 2490 Wilson 
St., Fort George G. Meade, MD 20755-5235, 301-677-7085, Testing for 
Department of Defense (DoD) Employees Only

Summer King,
Statistician.
[FR Doc. 2016-01819 Filed 2-1-16; 8:45 am]
BILLING CODE 4160-20-P

Federal Register / Vol. 81, No. 21 / Tuesday, February 2, 2016 / Notices 5473

DEPARTMENT OF HEALTH AND 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., SUMMARY: The Department of Health and
HUMAN SERVICES as amended. The grant applications and Human Services (HHS) notifies federal
the discussions could disclose agencies of the laboratories and
National Institutes of Health confidential trade secrets or commercial Instrumented Initial Testing Facilities
property such as patentable material, (IITF) currently certified to meet the
National Heart, Lung, and Blood and personal information concerning standards of the Mandatory Guidelines
Institute; Notice of Closed Meeting individuals associated with the grant for Federal Workplace Drug Testing
Pursuant to section 10(d) of the applications, the disclosure of which Programs (Mandatory Guidelines). The
Federal Advisory Committee Act, as would constitute a clearly unwarranted Mandatory Guidelines were first
amended (5 U.S.C. App.), notice is invasion of personal privacy. published in the Federal Register on
hereby given of the following meeting. Name of Committee: National Heart, Lung, April 11, 1988 (53 FR 11970), and
The meeting will be closed to the and Blood Institute Special Emphasis Panel; subsequently revised in the Federal
public in accordance with the PPG Review for Transfusion. Register on June 9, 1994 (59 FR 29908);
provisions set forth in sections Date: February 23, 2016. September 30, 1997 (62 FR 51118);
Time: 8:00 a.m. to 4:00 p.m. April 13, 2004 (69 FR 19644); November
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Agenda: To review and evaluate grant 25, 2008 (73 FR 71858); December 10,
as amended. The grant applications and applications.
the discussions could disclose 2008 (73 FR 75122); and on April 30,
Place: Bethesda Marriott Suites, 6711
confidential trade secrets or commercial Democracy Boulevard, Bethesda, MD 20817.
2010 (75 FR 22809).
property such as patentable material, Contact Person: Melissa E. Nagelin, Ph.D., A notice listing all currently HHS-
and personal information concerning Scientific Review Officer, Office of Scientific certified laboratories and IITFs is
individuals associated with the grant Review/DERA, National Heart, Lung, and published in the Federal Register
applications, the disclosure of which Blood Institute, 6701 Rockledge Drive, Room during the first week of each month. If
7202, Bethesda, MD 20892, 301–435–0297, any laboratory or IITF certification is
would constitute a clearly unwarranted
nagelinmh2@nhlbi.nih.gov. suspended or revoked, the laboratory or
invasion of personal privacy.
Name of Committee: National Heart, Lung, IITF will be omitted from subsequent
Name of Committee: Heart, Lung, and and Blood Institute Special Emphasis Panel; lists until such time as it is restored to
Blood Initial Review Group; NHLBI Methods for Measuring Tissue Oxygenation.
Mentored Patient-Oriented Research Review
full certification under the Mandatory
Date: February 25, 2016. Guidelines.
Committee. Time: 12:00 p.m. to 2:30 p.m.
Date: February 25–26, 2016. If any laboratory or IITF has
Agenda: To review and evaluate grant withdrawn from the HHS National
Time: 8:30 a.m. to 12:00 p.m. applications.
Agenda: To review and evaluate grant Place: National Institutes of Health, 6701
Laboratory Certification Program (NLCP)
applications. Rockledge Drive, Room 7192, Bethesda, MD during the past month, it will be listed
Place: Hilton Washington/Rockville, 1750 20892, (Telephone Conference Call). at the end and will be omitted from the
Rockville Pike, Rockville, MD 20852. Contact Person: Giuseppe Pintucci, Ph.D., monthly listing thereafter.
Contact Person: Stephanie Johnson Webb, Scientific Review Officer, Office of Scientific This notice is also available on the
Ph.D., Scientific Review Officer, Office of Review/DERA, National Heart, Lung, and Internet at http://www.samhsa.gov/
Scientific Review/DERA, National Heart, Blood Institute, 6701 Rockledge Drive, Room workplace.
Lung, and Blood Institute, 6701 Rockledge 7192, Bethesda, MD 20892, 301–435–0287,
Drive, Room 7196, Bethesda, MD 20892, 301– Pintuccig@nhlbi.nih.gov. FOR FURTHER INFORMATION CONTACT:
435–0291, stephanie.webb@nih.gov. Giselle Hersh, Division of Workplace
(Catalogue of Federal Domestic Assistance
(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Programs, SAMHSA/CSAP, 5600
Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Fishers Lane, Room 16N03A, Rockville,
Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Maryland 20857; 240–276–2600 (voice),
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases 240–276–2610 (fax).
Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes SUPPLEMENTARY INFORMATION: The
and Resources Research, National Institutes of Health, HHS)
of Health, HHS) Mandatory Guidelines were initially
Dated: January 27, 2016. developed in accordance with Executive
Dated: January 27, 2016.
Michelle Trout, Order 12564 and section 503 of Public
Michelle Trout, Law 100–71. The ‘‘Mandatory
Program Analyst, Office of Federal Advisory
Program Analyst, Office of Federal Advisory Committee Policy. Guidelines for Federal Workplace Drug
Committee Policy. Testing Programs,’’ as amended in the
[FR Doc. 2016–01817 Filed 2–1–16; 8:45 am]
[FR Doc. 2016–01816 Filed 2–1–16; 8:45 am] revisions listed above, requires strict
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P standards that laboratories and IITFs
must meet in order to conduct drug and
DEPARTMENT OF HEALTH AND specimen validity tests on urine
DEPARTMENT OF HEALTH AND HUMAN SERVICES specimens for federal agencies.
HUMAN SERVICES To become certified, an applicant
Substance Abuse and Mental Health laboratory or IITF must undergo three
National Institutes of Health Services Administration rounds of performance testing plus an
National Heart, Lung, and Blood on-site inspection. To maintain that
Current List of HHS-Certified certification, a laboratory or IITF must
Institute; Notice of Closed Meetings Laboratories and Instrumented Initial participate in a quarterly performance
wgreen on DSK2VPTVN1PROD with NOTICES

Pursuant to section 10(d) of the Testing Facilities Which Meet Minimum testing program plus undergo periodic,
Federal Advisory Committee Act, as Standards To Engage in Urine Drug on-site inspections.
amended (5 U.S.C. App.), notice is Testing for Federal Agencies Laboratories and IITFs in the
hereby given of the following meetings. AGENCY: Substance Abuse and Mental applicant stage of certification are not to
The meetings will be closed to the Health Services Administration, HHS. be considered as meeting the minimum
public in accordance with the requirements described in the HHS
ACTION: Notice.
provisions set forth in sections Mandatory Guidelines. A HHS-certified

VerDate Sep<11>2014 15:21 Feb 01, 2016 Jkt 238001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\02FEN1.SGM 02FEN1

5474 Federal Register / Vol. 81, No. 21 / Tuesday, February 2, 2016 / Notices

laboratory or IITF must have its letter of (Formerly: Gamma-Dynacare Medical 737–6370 (Formerly: SmithKline Beecham
certification from HHS/SAMHSA Laboratories) Clinical Laboratories)
(formerly: HHS/NIDA), which attests ElSohly Laboratories, Inc., 5 Industrial Park Redwood Toxicology Laboratory, 3700650
Drive, Oxford, MS 38655, 662–236–2609 Westwind Blvd., Santa Rosa, CA 95403,
that it has met minimum standards. Fortes Laboratories, Inc., 25749 SW., Canyon 800–255–2159
In accordance with the Mandatory Creek Road, Suite 600, Wilsonville, OR Southwest Laboratories, 4625 E. Cotton
Guidelines dated November 25, 2008 97070, 503–486–1023 Center Boulevard, Suite 177, Phoenix, AZ
(73 FR 71858), the following HHS- Laboratory Corporation of America Holdings, 85040, 602–438–8507/800–279–0027
certified laboratories and IITFs meet the 7207 N. Gessner Road, Houston, TX 77040, STERLING Reference Laboratories, 2617 East
minimum standards to conduct drug 713–856–8288/800–800–2387 L Street, Tacoma, Washington 98421, 800–
and specimen validity tests on urine Laboratory Corporation of America Holdings, 442–0438
specimens: 69 First Ave., Raritan, NJ 08869, 908–526– U.S. Army Forensic Toxicology Drug Testing
2400/800–437–4986 (Formerly: Roche Laboratory, 2490 Wilson St., Fort George G.
HHS-Certified Instrumented Initial Testing Biomedical Laboratories, Inc.) Meade, MD 20755–5235, 301–677–7085,
Facilities Laboratory Corporation of America Holdings, Testing for Department of Defense (DoD)
Dynacare, 6628 50th Street NW., Edmonton, 1904 Alexander Drive, Research Triangle Employees Only
AB Canada T6B 2N7, 780–784–1190 Park, NC 27709, 919–572–6900/800–833–
3984 (Formerly: LabCorp Occupational Summer King,
(Formerly: Gamma-Dynacare Medical
Testing Services, Inc., CompuChem Statistician.
Laboratories)
Laboratories, Inc.; CompuChem [FR Doc. 2016–01819 Filed 2–1–16; 8:45 am]
HHS-Certified Laboratories Laboratories, Inc., A Subsidiary of Roche BILLING CODE 4160–20–P
ACM Medical Laboratory, Inc., 160 Elmgrove Biomedical Laboratory; Roche
Park, Rochester, NY 14624, 585–429–2264 CompuChem Laboratories, Inc., A Member
Aegis Analytical Laboratories, Inc., 345 Hill of the Roche Group)
Ave., Nashville, TN 37210, 615–255–2400 Laboratory Corporation of America Holdings, DEPARTMENT OF HOMELAND
(Formerly: Aegis Sciences Corporation, 1120 Main Street, Southaven, MS 38671, SECURITY
Aegis Analytical Laboratories, Inc., Aegis 866–827–8042/800–233–6339 (Formerly:
Analytical Laboratories) LabCorp Occupational Testing Services, U.S. Citizenship and Immigration
Alere Toxicology Services, 1111 Newton St., Inc.; MedExpress/National Laboratory Services
Gretna, LA 70053, 504–361–8989/800– Center)
LabOne, Inc. d/b/a Quest Diagnostics, 10101 [OMB Control Number 1615–0087
433–3823 (Formerly: Kroll Laboratory
Specialists, Inc., Laboratory Specialists, Renner Blvd., Lenexa, KS 66219, 913–888–
3927/800–873–8845 (Formerly: Quest Agency Information Collection
Inc.)
Alere Toxicology Services, 450 Southlake Diagnostics Incorporated; LabOne, Inc.; Activities: Application for Citizenship
Blvd., Richmond, VA 23236, 804–378– Center for Laboratory Services, a Division and Issuance of Certificate Under
9130 (Formerly: Kroll Laboratory of LabOne, Inc.) Section 322, Form N–600K; Revision of
Specialists, Inc., Scientific Testing MedTox Laboratories, Inc., 402 W. County a Currently Approved Collection
Laboratories, Inc.; Kroll Scientific Testing Road D, St. Paul, MN 55112, 651–636–
Laboratories, Inc.) 7466/800–832–3244 AGENCY: U.S. Citizenship and
Baptist Medical Center-Toxicology MetroLab-Legacy Laboratory Services, 1225 Immigration Services, Department of
Laboratory, 11401 I–30, Little Rock, AR NE 2nd Ave., Portland, OR 97232, 503– Homeland Security.
413–5295/800–950–5295
72209–7056, 501–202–2783 (Formerly: ACTION: 60-Day notice.
Forensic Toxicology Laboratory Baptist Minneapolis Veterans Affairs Medical Center,
Medical Center) Forensic Toxicology Laboratory, 1 Veterans SUMMARY: The Department of Homeland
Clinical Reference Lab, 8433 Quivira Road, Drive, Minneapolis, MN 55417, 612–725– Security (DHS), U.S. Citizenship and
Lenexa, KS 66215–2802, 800–445–6917 2088, Testing for Veterans Affairs (VA)
Employees Only
Immigration (USCIS) invites the general
DrugScan, Inc., 200 Precision Road, Suite public and other Federal agencies to
200, Horsham, PA 19044, 800–235–4890 National Toxicology Laboratories, Inc., 1100
California Ave., Bakersfield, CA 93304, comment upon this proposed revision of
Dynacare ,* 245 Pall Mall Street, London,
661–322–4250/800–350–3515 a currently approved collection of
ONT, Canada N6A 1P4, 519–679–1630
One Source Toxicology Laboratory, Inc., 1213 information. In accordance with the
Genoa-Red Bluff, Pasadena, TX 77504, Paperwork Reduction Act (PRA) of
* The Standards Council of Canada (SCC) voted 888–747–3774 (Formerly: University of
to end its Laboratory Accreditation Program for 1995, the information collection notice
Substance Abuse (LAPSA) effective May 12, 1998.
Texas Medical Branch, Clinical Chemistry is published in the Federal Register to
Laboratories certified through that program were Division; UTMB Pathology-Toxicology
Laboratory)
obtain comments regarding the nature of
accredited to conduct forensic urine drug testing as the information collection, the
required by U.S. Department of Transportation Pacific Toxicology Laboratories, 9348 DeSoto
(DOT) regulations. As of that date, the certification Ave., Chatsworth, CA 91311, 800–328– categories of respondents, the estimated
of those accredited Canadian laboratories will 6942 (Formerly: Centinela Hospital Airport burden (i.e. the time, effort, and
continue under DOT authority. The responsibility Toxicology Laboratory) resources used by the respondents to
for conducting quarterly performance testing plus Pathology Associates Medical Laboratories, respond), the estimated cost to the
periodic on-site inspections of those LAPSA- 110 West Cliff Dr., Spokane, WA 99204,
accredited laboratories was transferred to the U.S. respondent, and the actual information
HHS, with the HHS’ NLCP contractor continuing to
509–755–8991/800–541–7891x7 collection instruments.
have an active role in the performance testing and Phamatech, Inc., 15175 Innovation Drive, San
Diego, CA 92128, 888–635–5840 DATES: Comments are encouraged and
laboratory inspection processes. Other Canadian
laboratories wishing to be considered for the NLCP Quest Diagnostics Incorporated, 1777 will be accepted for 60 days until April
may apply directly to the NLCP contractor just as Montreal Circle, Tucker, GA 30084, 800– 4, 2016.
U.S. laboratories do. 729–6432 (Formerly: SmithKline Beecham ADDRESSES: All submissions received
Upon finding a Canadian laboratory to be Clinical Laboratories; SmithKline Bio- must include the OMB Control Number
wgreen on DSK2VPTVN1PROD with NOTICES

qualified, HHS will recommend that DOT certify Science Laboratories)
the laboratory (Federal Register, July 16, 1996) as 1615–0087 in the subject box, the
Quest Diagnostics Incorporated, 400 Egypt
meeting the minimum standards of the Mandatory Road, Norristown, PA 19403, 610–631–
agency name and Docket ID USCIS–
Guidelines published in the Federal Register on
4600/877–642–2216 (Formerly: SmithKline 2007–0019. To avoid duplicate
April 30, 2010 (75 FR 22809). After receiving DOT submissions, please use only one of the
certification, the laboratory will be included in the Beecham Clinical Laboratories; SmithKline
monthly list of HHS-certified laboratories and Bio-Science Laboratories) following methods to submit comments:
participate in the NLCP certification maintenance Quest Diagnostics Incorporated, 8401 (1) Online. Submit comments via the
program. Fallbrook Ave., West Hills, CA 91304, 818– Federal eRulemaking Portal Web site at

VerDate Sep<11>2014 15:21 Feb 01, 2016 Jkt 238001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\02FEN1.SGM 02FEN1

Document Created: 2016-02-02 00:31:47
Document Modified: 2016-02-02 00:31:47

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice.
Contact		Giselle Hersh, Division of Workplace Programs, SAMHSA/CSAP, 5600 Fishers Lane, Room 16N03A, Rockville, Maryland 20857; 240-276-2600 (voice), 240-276-2610 (fax).
FR Citation		81 FR 5473

81 FR 5473 - Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICESSubstance Abuse and Mental Health Services Administration

Federal Register Volume 81, Issue 21 (February 2, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration